首页|Fraunhofer Institute for Silicate Research ISC Reports Findings in Robotics (ReB iA-Robotic Enabled Biological Automation: 3D Epithelial Tissue Production)
Fraunhofer Institute for Silicate Research ISC Reports Findings in Robotics (ReB iA-Robotic Enabled Biological Automation: 3D Epithelial Tissue Production)
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
New research on Robotics is the subjec t of a report. According to news reporting originating in Wurzburg, Germany, by NewsRx journalists, research stated, "The Food and Drug Administration's recent decision to eliminate mandatory animal testing for drug approval marks a signifi cant shift to alternative methods. Similarly, the European Parliament is advocat ing for a faster transition, reflecting public preference for animal-free resear ch practices." Financial support for this research came from Deutsche Forschungsgemeinschaft. The news reporters obtained a quote from the research from Fraunhofer Institute for Silicate Research ISC, "In vitro tissue models are increasingly recognized a s valuable tools for regulatory assessments before clinical trials, in line with the 3R principles (Replace, Reduce, Refine). Despite their potential, barriers such as the need for standardization, availability, and cost hinder their widesp read adoption. To address these challenges, the Robotic Enabled Biological Autom ation (ReBiA) system is developed. This system uses a dual-arm robot capable of standardizing laboratory processes within a closed automated environment, transl ating manual processes into automated ones. This reduces the need for process-sp ecific developments, making in vitro tissue models more consistent and cost-effe ctive. ReBiA's performance is demonstrated through producing human reconstructed epidermis, human airway epithelial models, and human intestinal organoids. Anal yses confirm that these models match the morphology and protein expression of ma nually prepared and native tissues, with similar cell viability."